Zobrazeno 1 - 10
of 293
pro vyhledávání: '"M Tubiana-Hulin"'
Autor:
René O. Mirimanoff, Nicolas Magné, Pierre Olivier, Jean Philippe Vuillez, Jean-Jacques Body, M. Tubiana-Hulin, Cyrus Chargari, Jean Léon Lagrange
Publikováno v:
Supportive Care in Cancer. 19:1565-1572
This study seeks to perform a survey of patterns of practice among the different physicians involved in the bone metastases management, with special focus on external beam radiotherapy (EBRT).A questionnaire about bone metastases based on clinical ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c1adde718afa2db008f75dc27c3c36b
https://doi.org/10.1007/s00520-010-0983-x
https://doi.org/10.1007/s00520-010-0983-x
Autor:
Armelle Dufresne, François Bertucci, Christine Chevreau, Binh Bui, Didier Cupissol, Marta Jimenez, J-Y. Blay, Nicolas Penel, A. Goncalves, D Perol, Isabelle Ray-Coquard, Pierre-Paul Bringuier, M. Tubiana-Hulin, A. Le Cesne
Publikováno v:
British Journal of Cancer
Background: Imatinib induces responses and disease stabilisations in non-resectable patients with aggressive fibromatosis (AF). The precise target of imatinib in AF and predictive factors for response to treatment are unknown. Methods: We investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b165ff66735c19934d8ea32205a1a3d0
https://doi.org/10.1038/sj.bjc.6605783
https://doi.org/10.1038/sj.bjc.6605783
Autor:
I. Bieche, C Andrieu, V Lazar, F. Spyratos, S Vacher, R. Lidereau, P Dessen, S Tozlu-Kara, Julie A. Vendrell, Pascale A. Cohen, M Tubiana-Hulin, V Roux
Publikováno v:
Journal of Molecular Endocrinology. 39:305-318
The estrogen receptor α (ERα) status of breast tumors is used to identify patients who may respond to endocrine agents such as tamoxifen. However, ERα status alone is not perfectly predictive, and there is a pressing need for more reliable markers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0165aafe2487dc0eaaf38415f89143e8
https://doi.org/10.1677/jme-07-0001
https://doi.org/10.1677/jme-07-0001
Autor:
M. Tubiana-Hulin
Publikováno v:
Cancer Treatment Reviews. 31:S3-S9
The life-expectancy of women with metastatic breast cancer (MBC) is closely linked to response to therapy. A significant increase in progression-free survival (PFS) and overall survival (OS) has been demonstrated in women who achieve a complete respo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fabe7eefe072cf41c233f0749367de5c
https://doi.org/10.1016/s0305-7372(05)80002-7
https://doi.org/10.1016/s0305-7372(05)80002-7
Autor:
F. Mayer, Stéphane Culine, B. Bendahmane, Véronique Diéras, N. Dohoulou, M. Tubiana-Hulin, Thierry Delozier, Jacques Bonneterre, Philippe Bougnoux, M.-E. Bonneterre
Publikováno v:
British Journal of Cancer
The purpose of the study was to evaluate the efficacy and safety of docetaxel plus epirubicin (ET) and of 5-fluorouracil plus epirubicin and cyclophosphamide (FEC) as first-line chemotherapy for metastatic breast cancer. A total of 142 patients (inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b58b7589c840de595eccb31b6052bb65
https://doi.org/10.1038/sj.bjc.6602179
https://doi.org/10.1038/sj.bjc.6602179
Autor:
M. Tubiana-Hulin
Publikováno v:
Oncologie. 6:129-135
Les metastases osseuses sont frequentes dans l’evolution du cancer du sein. Ceci entraine une morbidite considerable avec un taux eleve de complications osseuses, des douleurs severes, et une diminution de la qualite de vie. Les bisphosphonates son
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1830c435152de72acf426e45d405af5
https://doi.org/10.1007/s10269-004-0029-4
https://doi.org/10.1007/s10269-004-0029-4
Autor:
M Tubiana-Hulin, Nicole Tubiana-Mathieu, Moïse Namer, J C Eymard, Philippe Bougnoux, V Lotz, Marc Spielmann, H Mansouri
Publikováno v:
British Journal of Cancer
The aim of this study, using a Fleming single-stage design, was to explore the efficacy and safety of Taxotere® 100 mg m−2 docetaxel and FEC 75 cyclophosphamide 500 mg m−2, fluorouracil 500 mg m−2 and epirubicin 75 mg m−2, in alternating and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb9f961d796d63a4ead7c85c8ce4cda2
https://doi.org/10.1038/sj.bjc.6600165
https://doi.org/10.1038/sj.bjc.6600165
Autor:
M Tubiana-Hulin, Frédérique Spyratos, Michel Vidaud, Rosette Lidereau, K Hacene, Christophe Andrieu, Peter Onody, Ivan Bièche, Sengül Tozlu, Florence Lerebours
Publikováno v:
Cancer Letters. 174:173-178
We examined the relation between ERBB2 gene expression (as determined by a real-time quantitative RT-PCR assay) and the response to adjuvant tamoxifen therapy in a well-defined cohort of 125 ER α-positive postmenopausal patients with breast cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::398311a09453570c5e92a64dcf735610
https://doi.org/10.1016/s0304-3835(01)00696-6
https://doi.org/10.1016/s0304-3835(01)00696-6
Autor:
Jean-Pierre Julien, Cecile Vandervelden, M. Tubiana-Hulin, Jos A. van der Hage, Cornelis J.H. van de Velde, Luc Duchateau
Publikováno v:
Journal of Clinical Oncology. 19:4224-4237
PURPOSE: To evaluate whether preoperative neoadjuvant chemotherapy in patients with primary operable breast cancer results in better overall survival (OS) and relapse-free survival rates and whether preoperative chemotherapy permits more breast-conse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b42006b7aa33010fc7f2c979ce2025b
https://doi.org/10.1200/jco.2001.19.22.4224
https://doi.org/10.1200/jco.2001.19.22.4224
Autor:
F. Rückert, M. Pecherstorfer, Beat Thürlimann, M. Tubiana-Hulin, Marian Degardin, Ernst Steinhauer, Zuzana Herrmann, D. Thiébaud, René Rizzoli, Michael Clemens, Jean-Jacques Body, Houchingue Eghbali, Hermann Josef Huss, Christoph Manegold, Nigel J Bundred
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 84:3545-3550
The pathogenesis of hypercalcemia of malignancy comprises increased net bone resorption and enhanced renal tubular reabsorption of calcium (Ca). To evaluate the prevalence of an increased renal tubular reabsorption of Ca index [tubular reabsorption o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25a2dfca668f545347944d2a1eb86711
https://doi.org/10.1210/jcem.84.10.6026
https://doi.org/10.1210/jcem.84.10.6026